Benchlight The federal appellate judiciary

This writing

Type
Opinion
Author
Alan David Lourie
Filed
March 14, 2025
Case
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
Case status
Decided

Source The authoring judge was read from the signature line of the court's own published opinion.

Opening text

The first passage of the document, as extracted by the source provider.

Case: 24-2351 Document: 64 Page: 1 Filed: 03/14/2025 United States Court of Appeals for the Federal Circuit ______________________ REGENERON PHARMACEUTICALS, INC., Plaintiff-Appellant v. MYLAN PHARMACEUTICALS INC., AMGEN USA, INC., BIOCON BIOLOGICS INC., CELLTRION, INC., FORMYCON AG, SAMSUNG BIOEPIS CO., Defendants AMGEN INC., Defendant-A…

Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.

Read the full document (court PDF)